Guidance on off-label use of tocilizumab for UK COVID-19 patients published

A UK-wide position statement to support off-label prescribing and access to tocilizumab, administered intravenously, for eligible COVID-19 patients in intensive care has been published.
Source: The Pharmaceutical Journal - Category: Drugs & Pharmacology Source Type: research